Results 261 to 270 of about 48,575 (332)

Adding Ultralow-Dose Naltrexone to Oxycodone Enhances and Prolongs Analgesia: A Randomized, Controlled Trial of Oxytrex

, 2005
Vishala Chindalore, Richard Craven, Kevin Yu, P. Butera, Lindsay H. Burns, N. Friedmann   +5 more
openalex   +1 more source

Trial protocol of an open-label pilot study of oral <u>na</u>ltrexone-<u>bu</u>propion combination pharmacotherapy for the treatment of methamphetamine use disorder (the NABU trial). [PDF]

BMJ Open
Siefried KJ, Acheson L, Clifford B, Moller C, Brett J, Christmass M, Dunlop AJ, Haber PS, Jutras-Aswad D, Lintzeris N, Morley K, Shoptaw S, Trivedi MH, Ezard N.   +13 more
europepmc   +1 more source

Pharmacist administration of long-acting injectable medications for substance use disorders: A scoping review. [PDF]

Ment Health Clin
Hernandez Bustamante P, Charles A, Snider M, Catanzano S.   +3 more
europepmc   +1 more source

Safety and effects of anti-obesity medications on weight loss, cardiometabolic, and psychological outcomes in people living with overweight or obesity: a systematic review and meta-analysis. [PDF]

EClinicalMedicine
Liu L, Li Z, Ye W, Peng P, Wang Y, Wan L, Li J, Zhang M, Wang Y, Liu R, Xu D, Zhang J.   +11 more
europepmc   +1 more source

Pain Intensity in Patients with Opioid Use Disorder on Extended-Release Naltrexone or Opioid Agonists; The Role of COMT rs4680 and OPRM1 rs1799971: An Exploratory Study. [PDF]

J Pain Res
Juya F, Sannes AC, Solli KK, Weimand B, Gjerstad J, Tanum L, Mordal J.   +6 more
europepmc   +1 more source

Exploring the impact of a medication adherence intervention on recovery and mental health outcomes: A secondary analysis of the MAT-PLUS pilot RCT. [PDF]

Drug Alcohol Depend Rep
Wenzel K, Thomas J, Carrano J, Stidham J, Fishman M.   +4 more
europepmc   +1 more source

Barriers and facilitators to community pharmacist-provided injectable naltrexone for formerly incarcerated individuals during community reentry. [PDF]

Explor Res Clin Soc Pharm
Chladek JS, Chui MA.
europepmc   +1 more source

Characterization of the effect of naltrexone/bupropion on body composition. [PDF]

Diabetes Obes Metab
Tardio V, Yin P, Camacho F, Barakat M, Tsoukas MA.   +4 more
europepmc   +1 more source

Substance Use Treatment Services in New York (2021-2023): A State Profile Analysis Based on National Survey of Substance Abuse and Mental Health Services (N-SUMHSS) Data. [PDF]

Cureus
Arisoyin AE, Ezeani EI, Ekarika E, Odega AS, Ahumaraeze OO, Okobi OE.   +5 more
europepmc   +1 more source

Corrigendum to "Receipt of medication for opioid use disorder among rural and urban veterans health administration patients" [Drug Alcohol Depend. Rep. 14 (2025) 100311]. [PDF]

Drug Alcohol Depend Rep
Reynolds OC, Carlson KF, Gordon AJ, Handley RL, Morasco BJ, Korthuis TP, Lovejoy TI, Wyse JJ.   +7 more
europepmc   +1 more source